Dear Friends and Colleagues,
First and foremost, I would like to take this opportunity to thank you for your continued support.
Cosmo Corporate
The Year in Review & Optimism for 2023
Dear Friends and Colleagues,
Preparations for the post-COVID-19 era have opened up new challenges for all of us, including how to operate remotely and taking precautions, such as continuing to wear masks even in the workplace.
Japan is still preparing to cope with an eighth wave of COVID, although, work and life are generally back to normal.
The Year in Review & Optimism for 2022
Dear Friends and Colleagues,
This year is a special year for Cosmo Public Relations Corporation (“COSMO”). It marks our 60th anniversary. This occasion has allowed for some personal reflection on where COSMO has come from and where we would like to go in the future.
Announcement of personnel changes
Glen Sunohara, current President and Representative Director of J-CAN KK, has joined COSMO as Board Director as of January 1, 2021.
Glen will advise COSMO on short and long-term business plans and also leverage his experiences as an expert in healthcare to counsel the company on service enhancement and internal capability development.
Optimism for 2021
Happy New Year!
Each new year brings opportunity to bookmark our lives – to reflect and contemplate on our hopes for the year ahead. After the turmoil of last year I’m sure that, like me, you are more curious than ever of what the world will be like in 2021.
As a communications consulting firm specializing in healthcare, all of us at COSMO have been at the center of COVID-19, striving to help many healthcare companies and organizations that are committed to maintaining the health and quality of life of people in the midst of the pandemic.
In a shining example of the power of healthcare innovation, the latter half of 2020 finally brought some “light” at the end of the tunnel. We feel fortunate to have overcome the most difficult year in COSMO’s 60-year history.
Yet we cannot reflect on 2020 without thinking of those who suffered and still suffer from COVID-19, remembering those who have lost family members, friends, jobs, and much that was important to them.
Learning from the last year, COSMO will continue to evolve, be relevant, and seek to lead in every way. We have established three goals for 2021 to ensure we become a partner that makes even more impactful contributions to our clients’ businesses:
◇Continue to publish our Healthcare Insight Report, expanded to cover more therapeutic areas
Developed using COSMO’s proprietary patient survey data, our “Patient Insight Report: Cancer” was well-received after its publication last year. We will continue to publish the report and replicate its survey insight model for tracking healthcare trends across a range of disease areas and research topics.
◇Launch of patient advocacy portal site
As one of COSMO’s core services, a portal site dedicated to patient advocacy will be launched this year to promote the specialization to a wider audience. Serving as a hub, it will showcase best practices from Japan and abroad, creating a multi-stakeholder environment for developing patient-centric initiatives.
◇Launch of corporate reputation management tools and services
Corporate reputation is a critical business asset, but a lack of consistent metrics to evaluate it makes it difficult to manage long-term and strategically. COSMO will launch corporate reputation management tools and services this year that work in the Japanese market, drawing on best practices from global partners.
I hope that the anxiety and restrictions we have grown accustomed to will pass soon so that we may once again meet in person. It is my sincere wish that 2021 will be a special year for each and every one of you.
Kumi Sato,
President and CEO
Cosmo Public Relations Corporation
Cosmo PR and HekaBio Announce Strategic Partnership and Investment in HekaBio
Cosmo PR and HekaBio Announce Strategic Partnership and Investment in HekaBio
HekaBio K.K. (hereafter: HekaBio) and Cosmo Public Relations Corporation (hereafter: Cosmo) have announced that Cosmo has made an investment in HekaBio and that the companies have entered into a strategic partnership to increase awareness of and accessibility to emerging innovations in the bioscience field that will aid in meeting the needs of patients and society as a whole.
“I am delighted with Cosmo’s investment and the strategic partnership, which I believe will be highly synergistic as we develop and bring to market a broad range of MedTech and pharma innovations that are needed in Japan. In Cosmo’s Healthcare group (hereafter “Cosmo Healthcare”), we have a strong partner with shared values. Our partnership will enable us to make a greater contribution to society through our collaborative business activities. HekaBio specializes in early access to assets in development in worldwide biotech, regenerative medicine and MedTech ventures, and the success of these programs will be greatly enhanced through collaborations that can be forged in Cosmo Healthcare’s established network” said Rob Claar, CEO of HekaBio.
“Cosmo Healthcare is constantly looking for a way to broaden knowledge of cutting-edge innovations that will lead to healthcare advancements in Japan. HekaBio has such innovative programs that there is no overlap with the activities of any of our current clients. We look forward to working with HekaBio to introduce innovative ideas and create opportunities for the further development of pharmaceuticals, delivery systems and devices that can fulfill the needs of patients and help create a healthier society” said Kumi Sato, President and CEO of Cosmo.
About HekaBio K.K.
HekaBio is an ecosystem for accelerating healthcare innovations in Japan, operating as an in-licensing bio venture, a business development firm and a contract research organization (CRO). HekaBio focuses on solutions with high potential to address patients’ unmet medical needs and deliver cost savings for society. HekaBio currently has nearly 50 programs under management, many of which are new category innovations highly valued among Japanese clinicians.
About Cosmo Public Relations Corporation
Cosmo is a long-established leader in developing communications strategies across a broad range of life science specialties. It has a firm understanding of the Japanese healthcare regulatory framework, a wide network of experts across the entire healthcare sector and unrivaled contacts within the Japanese media. Its skills in qualitative and quantitative analyses make it adept at reading public sentiment and understanding the innovations of a broad range of healthcare professionals, thereby making it able to improve communication and match interests among different stakeholders.
Press Contact:
HekaBio K.K.
Mari Tanaka
email:mari.tanaka@hekabio.com
COSMO HEALTHCARE, Cosmo Public Relations Corporation
Yoko Awata
email:yoko.awata@cosmopr.co.jp
Optimism for 2020
We’re now a month into 2020, but this year is a significant milestone for COSMO, marking the 60th anniversary of our agency. Since our establishment in 1960, COSMO has evolved from providing editorial services for Japanese companies to being a pioneer in Japan’s communications industry, now specializing in globally-focused healthcare consultancy. A key driving force for COSMO’s business growth has always been to strive to make progress in our field. During this landmark year, we will continue to make advancements in healthcare communications that deliver meaningful value for our clients.
Dr. Hozumi hosts SwitchPoint Shibuya, an event focused on inventive approaches to solving health challenges in Africa
Dr. Dai Hozumi, a director at COSMO, will host “SwitchPoint Shibuya” on August 31, 2019.
SwitchPoint is a movement built around diverse gatherings of the smart, the curious, and the creative from all circles of humanitarian and global development work. SwitchPoint Shibuya is a globally curated event created in a partnership between IntraHealth International, The Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Japan Center for International Exchange focused on inventive approaches to solving health challenges in Africa. The event will feature talks and performances, interactive microlabs, and a networking reception.
COSMO PR’s Tomomi Nagasawa shortlisted for PR Professional of the Year (Agency) at PR Awards Asia 2019
Cosmo Public Relations Corp. today announced that their Deputy Managing Director, Tomomi Nagasawa, was shortlisted as PR Professional of the Year (Agency) at PR Awards Asia 2019. PR Awards Asia celebrates the most outstanding, inspired and successful campaigns, individuals and companies in Asia-Pacific’s communication industry.
Tomomi creates multi-stakeholder healthcare communication strategies to deliver the best client outcomes. She was instrumental in transforming COSMO to its current expertise in healthcare and biotech. Tomomi is also a role model for young Japanese women; she effectively wears three hats: she is the Deputy Managing Director of COSMO, she is the mother of a young child, and she is also a local politician’s wife. Balancing these vastly different duties, she exemplifies a new generation of Japanese women, who can have it all.
Navigating the Japan healthcare landscape over the past 12 months
After nearly 60 years in business since it was established, COSMO reflects on the past 12 months of helping MNCs navigate Japanese healthcare communications.
Healthcare Communication Consulting
Healthcare communications consultancy has grown further into our core offering since we first committed to this space over a decade ago. This year, COSMO was a leading consulting agency for one of the largest M&A deals by a Japanese company.
We also managed product launches across varied disease areas and proactively communicated clinical milestones. COSMO provided English and Japanese communication services across preclinical to launch phases for both established pharmaceutical companies and upcoming biotech companies.
IPRA Essay on Thought Leadership
Our President and CEO, Kumi Sato, recently had the opportunity to write for the International Public Relations Association’s Thought Leadership Essays.
Please follow this link to the original source, or read the article below.
COSMO on ICCO PR awards shortlist
COSMO PR has been shortlisted for the International Communications Consultancy Organization (ICCO) Global Awards for the 2017 Independent Consultancy of the Year. We are honored to be placed among our peers as the leading communications firms from the Asia Pacific region. Take a look at the complete shortlist of ICCO PR award candidates here.
コスモがICCO独立エージェンシー賞にノミネート
株式会社コスモ・ピーアールは、国際コミュニケーション・コンサルティング協会(the International Communications Consultancy Organization=ICCO、本部:英国ロンドン) によるグローバル賞の年間最優秀独立エージェンシー賞(2017 Independent Consultancy of the Year)にノミネートされました。ICCOによるPR賞ノミネートリストについては、こちらをご覧下さい。
COSMO Alum Baxter Jolly Wins SABRE Regional Consultancy of the Year
コスモの元ディレクターが国際的PR賞であるセイバー賞を受賞
株式会社コスモ・ピーアールで2000年代初頭にディレクターを務めたバクスター・ジョリー氏が現在、アジア太平洋部門を率いている国際的PR会社、ウェーバー・シャンドウィック・ワールドワイドが、2017年9月、セイバー賞の2017年アジア太平洋地域部門賞を受賞しました。私ども一同より、かつての同僚であったジョリー氏に対し、心からお祝いを申し上げます。
セイバー賞は、世界で最も権威あるPRの国際広告賞とされ、PR業界情報の専門会社ホルムス・レポートが運営しています。セイバー(Sabre)は「Superior Achievement in Branding and Reputation」(ブランディング及びレピュテーションの構築における優れた業績)の略で、その年にもっとも優れたPRキャンペーンを手がけたPR会社に与えられます。
授賞の対象となったのは、同社がインドで実施した映画「ドーターズ・オブ・マザー・インディア」のPRキャンペーン。この映画は女性に対する暴力を扱った2015年のドキュメンタリー作品で、同国で「社会問題における全国ベストフィルム賞」を獲得するなど、高い評価を得ました。
https://www.webershandwick.com/news/article/weber-shandwick-wins-consultancy-of-the-year-plus-6-categories-at-sabre-awa